Design, synthesis and anticancer activity of functionalized spiro-quinolines with barbituric and thiobarbituric acids
- 524 Downloads
A new series of spiro-quinoline compounds have been accomplished by the reaction of barbituric acid or thiobarbituric acid with derivatives of benzisoxazole-5-carbaldehyde or 2-substituted benzaldehyde. These compounds were evaluated for their in vitro cytotoxicity on two mammalian cancer cell lines MCF-7 and KB. The compounds exhibit cytotoxicity against these cell lines in micromolar range. Among the series of compounds, 11(a–j) particularly 11b and 11e showed relatively good activity against both the tested cell lines. Compound 11b was found to exhibit the highest cytotoxic activity with IC50 value 90.2 µM for MCF-7 and 49.8 µM for KB cell line. Flow cytometric analysis study confirmed that these molecules induced cytotoxicity via apoptosis.
KeywordsSpiro-quinoline Barbituric acid Benzisoxazole [1–5] Shift MTT assay Flow cytometry
Authors show deep sense of gratitude to Department of Science and Technology (SERB), New Delhi, India, for their financial assistance (SR/FT/CS-145/2010) to the present work. Authors GRV and BR thank Tumkur University administration for their support and encouragement.
Conflict of interest
- Brendan K, Michela M, Carolina M, Jorge EO, Javier MJ, Luis FC, Isabel R (2015) α2-Adrenoceptor antagonists: synthesis, pharmacological evaluation, and molecular modeling investigation of pyridinoguanidine, pyridino-2-aminoimidazoline and their derivatives. J Med Chem 58:963–977CrossRefGoogle Scholar
- Humar M, Andriopoulos N, Pischke SE, Loop T, Schmidt R, Hoetzel A, Roesslein M, Pahl HL, Geiger KK, Pannen BH (2004) Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small g proteins Ras and Rac-1. J Pharmacol Exp Ther 311:1232–1240PubMedCrossRefGoogle Scholar
- Jon JH, Todd JF, Karen AR, Joanne MS, Cailan W, Zhong S, James RC, Tianan F, Pancras CW, Alan RR, Frank AB, Jeffrey MB, Joseph ML, Carol AW, Ge Z, Anzhi W, Vidhyashankar R, Paul EM, Gregory SB, Srinath S, Piramanayagam A, Arvind M, Dietmar AS, Ruth RW, Mimi LQ (2014) Phenylimidazoles as potent and selective inhibitors of coagulation factor XIa with in vivo antithrombotic activity. J Med Chem 57:9915–9932CrossRefGoogle Scholar
- Massaro A, Mordini A, Reginato G, Russo F, Taddei M (2007) Microwave-assisted transformation of esters into hydroxamic acids. Synthesis. doi: 10.1055/s-2007-990803.
- Mimi LQ, Pancras CW, Cailan W, Francis W, Joanne MS, Frank AB, Jeffrey MB, Randi LB, Mark RH, Joseph ML, Paul EM, Tara P, Vidhyashankar R, Alan RR, Karen AR, Carol AW, Anzhi W, Ge Z, Dietmar S, Ruth RW (2014) Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors. J Med Chem 57:955–969CrossRefGoogle Scholar
- Onizuka S, Yonaha T, Tsuneyoshi I (2011) Local anesthetics with high lipophilicity are toxic, while local anesthetics with low pka induce more apoptosis in human leukemia cells. J Anesth Clin Res 2(1):1–5Google Scholar
- Patel DV, Gless RDJ, Webb H, Heather K, Anandan SK, Aavula BR (2008) Soluble epoxide hydrolase inhibitors. Int Patent WO 2008/073623 A2Google Scholar
- Romain G, Van LN, Jérôme T, Christophe S, Jean-Marie GB, Gael K, Olivier M, Alizon MR, Eric VB, Lionel T, Paul B, Hugh C, C C, Leanne C, Emmanuel HD, Rejbinder K, Antonia JL, Mark BS, Peter ES, Simon T, Ann LW, Walker MD, Rab KP, Edwige N (2014) The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor. J Med Chem 57:8111–8131CrossRefGoogle Scholar
- Schwarz M, Bonhotal J, Bischoff K, EbelJr JG (2013) Fate of barbiturates and non-steroidal anti-inflammatory drugs during carcass composting trends. Anim Vet Sci 4:1–12Google Scholar